NEW YORK (GenomeWeb News) – Genizon BioSciences has entered into a partnership with drug development consultancy Speid & Associates to offer that firm's clients access to Genizon's predictive techniques in the drug development process.

Speid's customers will use Genizon's genetic platform to identify and eliminate compounds that have a relatively low chance of success early in the drug development cycle.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Associated Press reports that the US government wasted $341,000 on travel by former Health and Human Services Secretary Tom Price.

Women who post YouTube science videos get more critical comments and more comments about their appearance than male video hosts, the New York Times reports.

The Wall Street Journal writes that participating in genetic research brings up the specter of past research ethics lapses for some African Americans.

In PLOS this week: sequences influencing yeast prion aggregation or degradation, dengue virus genetic variants affect transmission dynamics, and more.